Curis Inc. (CRIS) Fundamentals

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
SHARE INFORMATION
Market Cap$ 115,686,478
Shares Outstanding91,814,665
Float91,556,671
Percent Float99.72%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 10,649,000
Latest Fiscal EPS$ -0.50
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions283
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months14,753,514
Institutional Holdings Percent94.5%
Institutional Sold Previous 3 Months35,605,071
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.5
Insider Sold Previous 3 Months-
Insider Shares Owned2,319,042
TRADING INFO
52 Week High$ 9.04
52 Week Low$ 0.70
52 Week High Change$ -82.69
21 Day Moving Average$ 1.0659
21 Day Extended Moving Average$ 1.0804
50 Day Moving Average$ 1.0683
50 Day Extended Moving Average$ 1.1058
200 Day Moving Average$ 2.5911
200 Day Extended Moving Average$ 2.6497
10 Day Average Volume9,049,716
20 Day Average Volume5,393,639
30 Day Average Volume4,036,406
50 Day Average Volume3,895,754
Alpha0.023659
Beta2.6775
Standard Deviation0.662400
R20.040874
7 Day Price Change$ 0.19
7 Day Percent Change17.76%
21 Day Price Change$ 0.25
21 Day Percent Change24.75%
30 Day Price Change$ 0.10
30 Day Percent Change8.62%
Month to Date Price Change$ 0.2747
Month to Date Percent Change27.88%
Quarter to Date Price Change$ 0.2755
Quarter to Date Percent Change27.98%
180 Day Price Change$ -1.98
180 Day Percent Change-61.11%
200 Day Price Change$ -1.83
200 Day Percent Change-59.22%
Year to Date Price Change$ -3.50
Year to Date Percent Change-73.53%

Curis Inc. (CRIS) Key Ratios

PROFITABILITY
EBIT Margin-493.8%
EBITDA Margin-492.3%
Pre-Tax Profit Margin-376.6%
Profit Margin Count0.0%
Gross Margin96.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 10,624,000
Revenue Per Share$ 0.1157
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.80
Total Debt To Equity0.10
Int Coverage-12.30
Current Ratio9.30
Leverage Ratio1.80
Quick Ratio9.00
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-1.70
Enterprise Value$ -6,339,602
Price to Sales10.8892
Price to Free Cash-2.00
PE High Last 5 Years-2.90
Price To Book1.60
Price To Cash Flow0.00
PE Low Last 5 Years-6.60
Price to Tangible Book1.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.00
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-39.26
Return on Equity-70.27
Return on Capital-57.30

Curis Inc. (CRIS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOJames E. Dentzer
Emplyoees60
Last AuditUQ
CIK0001108205
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address128 Spring Street
Building C - Suite 500
Lexington, MA 2421
Websitehttps://www.curis.com
Facsimile+1 617 503-6501
Telephone+1 617 503-6500
Emailinfo@curis.com


Your Recent History
NASDAQ
CRIS
Curis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.